EX-99 3 ex99.txt JOINT FILER INFORMATION JOINT FILER INFORMATION This Form 4 is being filed jointly by the following parties: (i) Bernard C. Sherman ("Dr. Sherman"), who directly owns 11,250 shares of Barr Pharmaceuticals, Inc. (the "Issuer"), who has sole voting and dispositive control, as the sole trustee, of The Bernard Sherman 2000 Trust ("Sherman Trust"), and who owns 99% of the Outstanding capital stock of Sherman Holdings Inc. ("Sherman Holdings"); (ii) Sherman Trust which owns 99% of the common stock of Shermco, Inc. ("Shermco"); (iii) Sherman Holdings which owns 99% of the preferred stock of Shermco; (iv) Shermco which owns all of the outstanding capital stock of Sherfam Inc. ("Sherfam"); (v) Sherfam which owns all the outstanding capital stock of Apotex Holdings Inc. ("Apotex"); (vi) Apotex which owns all of the outstanding capital stock of SHERMFIN, INC. ("Shermfin"); (vii) Shermfin which owns all of the outstanding capital stock of Sherman Delaware, Inc. ("SDI"); (viii) SDI which directly owns, as of the date of this filing, 13,315,500 shares of common stock of the Issuer. Pursuant to Rule 16a-1(a)(4), the filing of this Form 4 shall not be deemed to be an admission by Dr. Sherman, Sherman Trust, Sherman Holdings, Shermco, Sherfam, Apotex and Shermfin that any of Dr. Sherman, Sherman Trust, Sherman Holdings, Shermco, Sherfam, Apotex and Shermfin is, for the purposes of Section 16 of the Securities Exchange Act of 1934, the beneficial owner of any securities covered by this Form 4. Name: Dr. Bernard C. Sherman Address: 150 Signet Drive, Weston, Ontario, Canada M9L 1T9 Designated Filer: Sherman Delaware, Inc. Issuer and Ticker Symbol: Barr Pharmaceuticals, Inc. (BRL) Date of Event Requiring Statement: March 18, 2004 /s/ Bernard C. Sherman Bernard C. Sherman Name: The Bernard Sherman 2000 Trust Name: Apotex Holdings Inc. Address: 150 Signet Drive, Weston, Address: 150 Signet Drive, Weston, Ontario, Canada M9L 1T9 Ontario, Canada M9L 1T9 Designated Filer: Sherman Delaware, Inc. Designated Filer: Sherman Delaware, Inc. Issuer and Ticker Symbol: Barr Issuer and Ticker Symbol: Barr Pharmaceuticals, Inc. (BRL) Pharmaceuticals, Inc. (BRL) Date of Event Date of Event Requiring Statement: March 18, 2004 Requiring Statement: March 18, 2004 By: /s/ Bernard C. Sherman By: /s/ Bernard C. Sherman ------------------ ------------------ Bernard C. Sherman Bernard C. Sherman Sole Trustee President
Name: Sherman Holdings Inc. Name: SHERMFIN, INC. Address: 150 Signet Drive, Weston, Address: 150 Signet Drive, Weston, Ontario, Canada M9L 1T9 Ontario, Canada M9L 1T9 Designated Filer: Sherman Delaware, Inc. Designated Filer: Sherman Delaware, Inc. Issuer and Ticker Symbol: Barr Issuer and Ticker Symbol: Barr Pharmaceuticals, Inc. (BRL) Pharmaceuticals, Inc. (BRL) Date of Event Date of Event Requiring Statement: March 18, 2004 Requiring Statement: March 18, 2004 By: /s/ Bernard C. Sherman By: /s/ Bernard C. Sherman ------------------ ------------------ Bernard C. Sherman Bernard C. Sherman President President Name: Shermco Inc. Name: Sherfam Inc. Address: 150 Signet Drive, Weston, Address: 150 Signet Drive, Weston, Ontario, Canada M9L 1T9 Ontario, Canada M9L 1T9 Designated Filer: Sherman Delaware, Inc. Designated Filer: Sherman Delaware, Inc. Issuer and Ticker Symbol: Barr Issuer and Ticker Symbol: Barr Pharmaceuticals, Inc. (BRL) Pharmaceuticals, Inc. (BRL) Date of Event Date of Event Requiring Statement: March 18, 2004 Requiring Statement: March 18, 2004 By: /s/ Bernard C. Sherman By: /s/ Bernard C. Sherman ------------------- ------------------ Bernard C. Sherman Bernard C. Sherman Chairman Chairman